Abstract 4330: <i>In vivo</i> evaluation of anti-tumor activity by an anti-VEGF and anti-DLL4 bispecific antibody in a humanized model of skin graft.
Lucia Beviglia(OncoMed (United States)), Timothy Hoey, Janak Raval(OncoMed (United States)), Sato Aaron(OncoMed (United States)), Fumiko Axelrod(OncoMed (United States)), Belinda Cancilla(OncoMed (United States)), Pete Yeung(OncoMed (United States)), Ann M. Kapoun(OncoMed (United States)), Wang-Ching Yen(OncoMed (United States)), Chris Bond(OncoMed (United States)), Shirley Ma(University of Maryland Center for Environmental Science), Cécile Chartier(Io Therapeutics (United States)), Austin Gurney(Australian Centre for Heart Health), John Lewicki(OncoMed (United States))
Cited by 0
Related Papers
Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli
|Journal of Virology|1996|651
Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors
|Proceedings of the National Academy of Sciences|2012|630
Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy
|PLoS ONE|2008|582
Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma
|Journal of Clinical Oncology|2021|431
IL-17E, a Novel Proinflammatory Ligand for the IL-17 Receptor Homolog IL-17Rh1
|Journal of Biological Chemistry|2001|410